A six months, randomised, open, parallel group, multicentre study to examine efficacy ans safety of as needed versus maintenance use of Oxis Turbuhaler (Formoterol) 9 microgram in subjects well controlled on maitenance treatment with inhaled corticosteroids and long-acting beta2-agonist

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].